Immunochem is a small company active in the IVD sector, specialised in the generation of high quality antibodies. Building on this expertise, Immunochem holds a promising idea by setting up new research and development projects tackling the AMR problematic.
The principal focus at Immunochem is antibody development and sales, especially polyclonal antibodies raised against steroid hormones. For more than 20 years, Immunochem was able to produce and sell high quality and highly sensitive antibodies to clients that would manufacture in-vitro diagnostic (IVD) kits. Beginning of 2023, Immunochem will develop its proprietary discovery platform of single-domain antibodies to pursue further research and fulfill its clients needs.